About

About MediNect Ophtho MediNect Ophtho is a specialist preclinical research division of MediNect Bioservices Ltd., focused on accelerating therapeutic development for retinal and ocular diseases. The team combines deep expertise in in vivo, ex vivo, and advanced in vitro models, including diabetic macular edema, retinal degeneration, and subretinal fibrosis. With a strong scientific foundation—over 80% of staff holding PhDs—and leadership experienced in advancing drugs to clinical trials, MediNect Ophtho delivers high-quality, translational data to support decision-making from early discovery through to IND-enabling studies. By integrating academic insight with CRO delivery, the group provides flexible, bespoke study design tailored to biotech and pharmaceutical partners worldwide.